Jing Zhao

Education

Ph.D., biology, Baylor College of Medicine; M.S., biostatistics, Harvard T.H. Chan School of Public Health; B.S., biological science and biotechnology, Tsinghua University, China

Summary of Experience

Dr. Zhao draws on her background in biology and biostatistics in her research on the value of health care products and her work on analytics across the product life cycle. She has broad experience with the development and implementation of health economics and outcomes research (HEOR) strategies in a number of therapeutic areas, including diabetes, oncology, immunology, infectious diseases, and hematology. Dr. Zhao applies advanced research methods for health care data to real-world evidence development, individualized medicine, predictive analytics, and cost-effectiveness analysis. Her work has been used to inform health care regulators and payers in US and global markets, published in peer-reviewed journals, and presented at clinical and economic research conferences.

Selected Publishing

• Assessment of income growth in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy

  Journal of Medical Economics, 2021
  2021

  Parikh ND, Marshall A, Betts KA, Song J, Zhao J, Yuan M, Wu A, Huff KD, Kim R

  Health Care
• Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma

  Clinical Therapeutics, 2019
  2019

  Telford C, Kabadi SM, Abhyankar S, Song J, Signorovitch J, Zhao J, Yao Z

  Health Care
• Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America

  Advances in Therapy, 2019
  2019

  Muniz DQ, Ratto B, Yang H, Zhao J, Jenkins M, Signorovitch J, Dezzani L, Salman P, Medina ML, Lopera D, Lerzo G, Del Castillo C, Chacon M, Martin A, Campos-Gomez S

  Health Care
• Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants

  Frontiers in Pediatrics, 2019
  2019

  Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP

  Health Care
• Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

  Therapeutics and Clinical Risk Management. 2018 Jul 25;14:1267-1277
  2018

  Chen KS, Xie J, Tang W, Zhao J, Jeppesen PB, Signorovitch JE

  Health Care
• Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data

  BMJ Open. 2018 Aug 17;8(8):e021642
  2018

  Li J, Sasane M, Zhang J, Zhao J, Ricculli ML, Yao Z, Redhu S, Signorovitch J

  Health Care
• Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis

  Advances in Therapy. 2018 Jul;35(7):1035-1048
  2018

  Li J, Sasane M, Zhao J, García-Horton V, Zhang P, Ricculli ML, Zhou ZY, Signorovitch J

  Health Care
• Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study

  Diabetes Therapy. Jun 2017;8(3):555-571
  2017

  Zhou Z, Chaudhari P, Yang H, Fang AP, Zhao J, Law EH, Wu EQ, Jiang R, Seifeldin R

  Health Care
• A Risk Score for Fluconazole Failure among Patients with Candidemia

  Antimicrobial Agents Chemotherapy. 2017 Apr 24;61(5). pii: e02091-16. doi: 10.1128/AAC.02091-16. Print 2017 May.
  2017

  Yang H, Ostrosky-Zeichner L, Harrington R, Azie N, Li N, Zhao J, Koo V, Wu EQ

  Health Care